They help regulate blood sugar, slow digestion, and signal fullness, which is why many people experience a reduced appetite and weight loss
Similarly, Wegovy, initially known for its weight loss effects, was approved in August 2025 for the treatment of metabolic dysfunction-associated steatohepatitis (MASH)
Which Drugs Are Covered The three GLP-1 medications covered under the Bridge are: Wegovy (semaglutide) all approved formulations Zepbound (tirzepatide) KwikPen formulation only (the single-dose vial and single-dose pen formulations of Zepbound are excluded) Foundayo (orforglipron) the oral GLP-1 option, all formulations All three are available at the $50 monthly copay for eligible enrollees
It May Boost Brain Health Courtesy of caffeine and theobromine (a similar plant-based stimulant), yerba mate can boost alertness and mental clarity, says Dr
It is the fastest way to get a muscle-preserving program dialed in on a GLP-1